Suppr超能文献

从生理学到药理学:复发性尿路感染的发病机制和治疗的进展。

From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections.

机构信息

Department of Molecular Microbiology and Microbial Pathogenesis; Center for Women's Infectious Disease Research, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8230, Saint Louis, MO, 63110, USA.

出版信息

Curr Urol Rep. 2013 Oct;14(5):448-56. doi: 10.1007/s11934-013-0354-5.

Abstract

Urinary tract infections (UTIs) are common, and over half of women report having had at least one in their lifetime. Nearly a third of these women experience recurrent UTI episodes, but the mechanisms of these recurrences are not fully elucidated. Frequent use of antimicrobials for treatment and prevention of UTIs and other infections has contributed to the evolution of multidrug-resistant microorganisms globally. This is a looming worldwide crisis that has created an urgent need for novel strategies for the treatment and prevention of UTIs. Furthering our understanding of the mechanisms of recurrent UTIs, from both host and bacterial perspectives, will be paramount in developing targeted management strategies. In this review, we discuss recent findings regarding recurrent UTIs in women, including progress in our understanding of the mechanisms of recurrence as well as emerging treatments.

摘要

尿路感染(UTIs)很常见,超过一半的女性报告一生中至少患过一次。这些女性中有近三分之一经历过复发性尿路感染发作,但这些复发的机制尚未完全阐明。频繁使用抗生素治疗和预防尿路感染和其他感染导致了全球多药耐药微生物的进化。这是一场迫在眉睫的全球危机,迫切需要新的策略来治疗和预防尿路感染。从宿主和细菌两个方面进一步了解复发性尿路感染的机制对于制定有针对性的管理策略至关重要。在这篇综述中,我们讨论了女性复发性尿路感染的最新发现,包括我们对复发机制的理解以及新出现的治疗方法的进展。

相似文献

3
Pharmacotherapeutic advances for recurrent urinary tract infections in women.
Expert Opin Pharmacother. 2020 Nov;21(16):2011-2026. doi: 10.1080/14656566.2020.1795128. Epub 2020 Jul 27.
4
Recurrent UTI in Women-Risk Factors and Management.
Infect Dis Clin North Am. 2024 Jun;38(2):325-341. doi: 10.1016/j.idc.2024.03.010. Epub 2024 Apr 10.
10
Management of uncomplicated recurrent urinary tract infections.
BJU Int. 2022 Jun;129(6):668-678. doi: 10.1111/bju.15630. Epub 2021 Nov 17.

引用本文的文献

4
Urinary tract infections: a retrospective cohort study of (mis)matching antimicrobial therapy and clinical outcome among Finnish adults.
JAC Antimicrob Resist. 2024 Nov 26;6(6):dlae188. doi: 10.1093/jacamr/dlae188. eCollection 2024 Dec.
6
A cynomolgus monkey urinary tract infection model confirms efficacy of new FimH vaccine candidates.
Infect Immun. 2024 Oct 15;92(10):e0016924. doi: 10.1128/iai.00169-24. Epub 2024 Sep 19.
7
Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics.
Nat Rev Microbiol. 2025 Feb;23(2):72-86. doi: 10.1038/s41579-024-01092-4. Epub 2024 Sep 9.
8
Role of N-acetylkynurenine in mediating the effect of gut microbiota on urinary tract infection: a Mendelian randomization study.
Front Microbiol. 2024 Apr 22;15:1384095. doi: 10.3389/fmicb.2024.1384095. eCollection 2024.
10
Urinary Tract Infections Caused by Uropathogenic : Mechanisms of Infection and Treatment Options.
Int J Mol Sci. 2023 Jun 23;24(13):10537. doi: 10.3390/ijms241310537.

本文引用的文献

2
Urine post equivalent daily cranberry juice consumption may opsonize uropathogenicity of Escherichia coli.
J Infect Chemother. 2013 Oct;19(5):812-7. doi: 10.1007/s10156-013-0565-1. Epub 2013 Feb 26.
3
The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli.
Infect Immun. 2013 May;81(5):1450-9. doi: 10.1128/IAI.01213-12. Epub 2013 Feb 19.
5
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.
World J Urol. 2013 Dec;31(6):1427-32. doi: 10.1007/s00345-013-1031-5. Epub 2013 Jan 29.
6
Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model.
Infect Immun. 2013 Mar;81(3):733-9. doi: 10.1128/IAI.01234-12. Epub 2012 Dec 21.
7
Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli.
Mol Immunol. 2013 May;54(1):32-9. doi: 10.1016/j.molimm.2012.11.002. Epub 2012 Dec 3.
8
OmpR regulation of the uropathogenic Escherichia coli fimB gene in an acidic/high osmolality environment.
Microbiology (Reading). 2013 Feb;159(Pt 2):316-327. doi: 10.1099/mic.0.059386-0. Epub 2012 Nov 22.
10
Target Selectivity of FimH Antagonists.
J Med Chem. 2012 Nov 26;55(22):9810-6. doi: 10.1021/jm3010338. Epub 2012 Nov 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验